$123.67
2.62% day before yesterday
NYSE, Jul 18, 10:08 pm CET
ISIN
US0028241000
Symbol
ABT

Abbott Laboratories Stock price

$123.67
-8.74 6.60% 1M
+10.19 8.98% 6M
+10.56 9.34% YTD
+23.60 23.58% 1Y
+16.65 15.56% 3Y
+24.59 24.82% 5Y
+73.61 147.04% 10Y
+101.46 456.92% 20Y
NYSE, Closing price Fri, Jul 18 2025
+3.16 2.62%
ISIN
US0028241000
Symbol
ABT
Sector

Key metrics

Basic
Market capitalization
$215.2b
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
15.5 | 23.7
P/S
5.0 | 4.8
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
$2.24
Yield 1Y | 5Y
1.8% | 1.8%
Growth 1Y | 5Y
7.7% | 11.2%
Payout 1Y | 3Y
29.2% | 42.0%
Increased
11 Years
Financials (TTM | estimate)
Revenue
$43.1b | $45.1b
EBITDA
$9.5b | $12.2b
EBIT
$7.7b | $10.4b
Net Income
$14.0b | -
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
5.9% | 7.6%
EBITDA
9.1% | 37.1%
EBIT
13.8% | 49.0%
Net Income
151.6% | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
56.2%
EBITDA
22.0% | 27.0%
EBIT
17.9%
Net
32.4% | -
Free Cash Flow
-
Financial Health
Equity Ratio
58.6%
Return on Equity
28.1%
ROCE
-
ROIC
-
Debt/Equity
-
More
EPS
$8.0
FCF per Share
-
Short interest
1.2%
Employees
114k
Rev per Employee
$370.0k
Show more

Is Abbott Laboratories a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,009 stocks worldwide.

Abbott Laboratories Stock Analysis

Unlock Scores for Free

Analyst Opinions

33 Analysts have issued a Abbott Laboratories forecast:

21x Buy
64%
12x Hold
36%

Analyst Opinions

33 Analysts have issued a Abbott Laboratories forecast:

Buy
64%
Hold
36%

Financial data from Abbott Laboratories

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
43,109 43,109
6% 6%
100%
- Direct Costs 18,882 18,882
4% 4%
44%
24,227 24,227
7% 7%
56%
- Selling and Administrative Expenses 11,918 11,918
6% 6%
28%
- Research and Development Expense 2,837 2,837
9% 9%
7%
9,472 9,472
9% 9%
22%
- Depreciation and Amortization 1,775 1,775
8% 8%
4%
EBIT (Operating Income) EBIT 7,697 7,697
14% 14%
18%
Net Profit 13,979 13,979
152% 152%
32%

In millions USD.

Don't miss a Thing! We will send you all news about Abbott Laboratories directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Abbott Laboratories Stock News

Positive
MarketBeat
one day ago
If you wonder whether Abbott Laboratories NYSE: ABT is a good buy in Q2 2025, the answer is yes. The company's management, portfolio, cash flow, capital return, and pipeline are why.
Positive
Seeking Alpha
one day ago
ABT, which had been outperforming the healthcare cohort from the S&P 500 and the S&P 500 itself all through this year, has slumped dramatically following yesterday's Q2 earnings. While Q2 sales beat expectations, with YoY growth rising to its highest point in 3 years, earnings merely met estimates, disappointing given the company's history of bottom-line beats averaging 9%. ABT's second-largest...
Neutral
CNBC
2 days ago
Abbott Laboratories CEO Robert Ford unpacked his company's latest quarterly report in a Thursday interview with CNBC's Jim Cramer, saying that Wall Street's reaction to the results was too extreme. "I think this is a little bit of an overreaction.
More Abbott Laboratories News

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Head office United States
CEO Robert Ford
Employees 114,000
Founded 1888
Website www.abbott.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today